Veronika Papon

Ms. Veronika Papon


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Health & Social Care in the Community
Verified
Journal Article
Open access
URUrsula Rochau
Ursula Rochau
VPVeronika Papon
Veronika Papon
ISIgor Stojkov
Igor Stojkov
FKFelicitas Kühne
Felicitas Kühne
MAMarjan Arvandi
Marjan Arvandi
SPSibylle Puntscher
Sibylle Puntscher
Nature‐based social prescribing (NBSP) is an evolving subject aiming to reduce loneliness and to foster social connections, health, and well‐being. To evaluate the short‐term and long‐term consequences of different health technologies, decision‐analytic modeling can be applied. Decision‐analytic modeling studies systematically integrate current short‐ and long‐term evidence to weigh benefits, harms, and costs of different strategies. Our systematic literature review identified and assessed decision‐analytic modeling studies addressing specifically NBSP or other interventions aiming to reduce loneliness. Predefined inclusion/exclusion criteria guided our systematic literature search in five databases. Title/abstract screening and full‐text screening were conducted by two independent reviewers. An a priori defined extraction table included country, intervention, and model type. The Philips framework was used to evaluate the quality of the studies. Overall, 3273 studies were identified, and 16 studies were eligible for full‐text screening. None of these studies applied a decision‐analytic model specifically to NBSP. However, two studies compared interventions for reducing loneliness. One study was conducted in Australia and performed a cost‐utility analysis, resulting in cost‐saving results and a positive return on investment. The second study was conducted in England and applied a cost‐effectiveness analysis resulting in 768 British pounds per loneliness‐free year gained. Overall, the evaluated interventions can be regarded as cost‐effective, and in some instances, they have the potential to save costs. Further research on the connection of loneliness, overall health, social well‐being, and quality of life and their integration into decision‐analytic studies is needed.

25 May 2026 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
VPVeronika Papon
Veronika Papon
SPSibylle Puntscher
Sibylle Puntscher
MMMontse Masó-Aguado
Montse Masó-Aguado
MAMarjan Arvandi
Marjan Arvandi
BJBeate Jahn
Beate Jahn
URUrsula Rochau
Ursula Rochau
Introduction: Loneliness is associated with adverse health outcomes, including cardiovascular diseases, depression, and premature mortality, and is unequally distributed according to social determinants. Prescribing individuals to community-based interventions in nature, often described as nature-based social prescribing (NBSP), has emerged as a promising intervention to address loneliness. This study aims to quantify the social return of investment (SROI) of the “Friends in Nature” (FiN) intervention designed to alleviate loneliness. Methods: Following key guidelines, we performed a SROI study for a NBSP intervention compared to usual care alongside the FiN trial conducted in Barcelona within the EU-H2020 RECETAS project. The SROI ratio, which measures the social value generated per monetary unit invested, and the net present value, which reflects the difference between social value and investment costs, were estimated. Results: A social return of EUR 1.48 per EUR 1 invested in the NBSP intervention was generated. The net present value was EUR 8,585 per FiN and EUR 8,496 per UC participant. The SROI ratios remained positive and above one in most sensitivity and scenario analyses, ranging from EUR 0.83 to 13.18 per 1 EUR invested. Discussion: We conducted a SROI analysis to quantify the broader benefits of investing in a NBSP intervention to reduce loneliness. This SROI ratio enables decision-makers to consider social value alongside financial value, thereby facilitating more comprehensive comparisons of public health investments. Clinical trial registration: Trial Registration: ClinicalTrials.gov , ID: NCT05488496. Registered 29 July 2022.

1 July 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
VPVeronika Papon
Veronika Papon
JSJonas Schöpf
Jonas Schöpf
JLJill Litt
Jill Litt
MAMarjan Arvandi
Marjan Arvandi
NONerkez Opacin
Nerkez Opacin
SPSibylle Puntscher
Sibylle Puntscher
Background/Objectives: Social Prescribing (SP) seeks to address non-medical needs by connecting individuals to community-based resources through a person-centered “social prescription”, such as group activities or support services. SP is increasingly being implemented internationally and has demonstrated potential benefits for wellbeing. However, potential harms and negative or unintended consequences (HNUCs) remain poorly understood. This scoping review aims to synthesize evidence on HNUCs reported in the literature. Methods: A systematic search of EMBASE, MEDLINE, and APA PsycInfo was conducted through September 2024 to identify full-text studies published in English or German that report HNUCs associated with SP for adults in health- or social care settings. Backward reference searches of relevant reviews identified additional studies. Two reviewers screened and extracted data independently, with disagreements resolved by a third reviewer. Study characteristics and HNUCs were categorized using the Consequences of Public Health Interventions (CONSEQUENT) framework, by level (service users, stakeholders, or system level) and degree of certainty (explicit, implicit, or potential). We followed the Joanna Briggs Institute manual and the PRISMA Reporting Guidelines for Scoping Reviews. Results: Of 2097 records identified, 18 primary studies met the inclusion criteria. In addition, 87 studies, identified through 35 included reviews, were analyzed. A total of 776 unique HNUCs were identified across the CONSEQUENT framework’s domains. Most were related to the domains of “Health System”, “Health” and “Acceptability and Adherence”, and predominantly affected SP participants. Conclusions: SP may be associated with potential HNUCs affecting users, stakeholders, and systems. Identifying and addressing these risks is essential for designing, implementing, and evaluating SP programs, and guiding future research to mitigate potential HNUCs. Our findings underscore the importance of policymakers and practitioners incorporating the routine monitoring of unintended consequences and using this evidence to inform program refinement, resource allocation, and harm mitigation strategies.

14 March 2026 in BMC Primary Care
Verified
Journal Article
Open access
PDF file
SPSibylle Puntscher
Sibylle Puntscher
ISIgor Stojkov
Igor Stojkov
MAMarjan Arvandi
Marjan Arvandi
FKFelicitas Kühne
Felicitas Kühne
ACAnnette Conrads-Frank
Annette Conrads-Frank
URUrsula Rochau
Ursula Rochau
Background: Nature-based social prescribing (NBSP) is a form of social prescribing that can enhance mental and/or physical health by connecting participants with nature through non-medical community referrals. While evidence suggests potential benefits of NBSP in promoting well-being, its economic impact remains unclear. The purpose of our systematic literature review is to investigate the health-economic impact of NBSP programs. Methods: We searched six databases in July 2024. Two reviewers independently screened publications for eligibility: (1) NBSP interventions for health improvement among adults (2), partial or complete economic analyses, and (3) peer-reviewed original studies, published in English, Spanish, or German after the year 2000. Eligible data were systematically extracted by two independent authors into an extraction form including standardized information on the publication, population and setting, compared strategies, details of the analytic framework, main results, limitations, and study conclusions. This information was further synthesized in an evidence table and analyzed using a narrative synthesis approach, with results summarized for each study. The quality of the included studies was assessed using the Consensus Health Economic Criteria list. The review followed PRISMA guideline and is registered on PROSPERO (CRD42021286176). Results: Of the 2,985 hits identified, five studies met the inclusion criteria, all of which were conducted in the United Kingdom (UK) and included people with mild mental and/or physical health issues. The time horizon ranged from twelve weeks to ten years. Three studies conducted a social return on investment (SROI) analysis and reported SROI ratios between 2.6 and 5.1 British pounds (GBP) per GBP invested. One cost-benefit study identified economic returns of 6,000–14,000 GBP per person after one year, with potential returns of up to 8,600 − 24,500 GBP per person after ten years. One cost-utility analysis resulted in costs of 8,600 GBP per quality-adjusted life year gained. Conclusions: Evidence on the health and economic impacts of NBSP is currently limited. The five identified studies, all based in the UK, generally reported favorable health and economic findings. However, the small number of studies, their methodological limitations, and the exclusive UK focus constrain the generalizability of these conclusions. To better inform healthcare decision-making and to implement NBSP programs worldwide, further research on NBSP interventions and their economic impact is needed. Consequently, future studies should explore international settings, incorporate additional data sources, include control groups, and assess longer follow-up periods.

9 May 2026 in BMC Public Health
Verified
Journal Article
Open access
PDF file
VPVeronika Papon
Veronika Papon
SPSibylle Puntscher
Sibylle Puntscher
MAMarjan Arvandi
Marjan Arvandi
BJBeate Jahn
Beate Jahn
JLJill Litt
Jill Litt
URUrsula Rochau
Ursula Rochau
Background: Loneliness has become a global public health problem associated with serious diseases and early mortality. A promising non-medical group-based strategy to address loneliness is nature-based social prescribing (NBSP). The aim of this paper is to describe the design of a health economic evaluation of NBSP interventions alongside trials conducted in the EU H2020 project RECETAS. Methods: The health economic evaluation will be conducted alongside the RECETAS randomized controlled trials in Barcelona, Prague, and Helsinki, and comprises cost-utility, cost-effectiveness, and cost-capability analyses. Depending on each study site’s specific setting and target population, the economic evaluation will be performed from a societal and/or a healthcare perspective. NBSP interventions, which include referring lonely people to participate in activities organized in a natural environment and providing a selection of nearby nature-based community resources, will be evaluated against usual care. Effectiveness measures include health-related quality of life assessed with the EQ-5D-5 L questionnaire, changes in loneliness obtained from the De Jong Gierveld Loneliness Scale, and capability derived from the ICECAP-A questionnaire. Direct healthcare costs, indirect and informal costs as well as the actual costs of the intervention will be included. The data on health outcome and health care resource utilization will be collected at baseline and at three-, six- and twelve-months follow-up of the trial. The incremental cost-utility ratio, incremental cost-effectiveness ratio, and incremental cost-capability ratio will be calculated. National willingness-to-pay thresholds will be applied where available. Discussion: Our study protocol provides a systematic framework designed prospectively for conducting the health economic evaluation of the NBSP intervention for people suffering from loneliness. Through the publication of the study protocol, the research process becomes transparent and reproducible. This reduces bias when interpreting the results and conclusions and ensures good evidence-based practice, so that decision makers can provide evidence-based recommendations without arbitrariness to support NBSP implementation. Trial registration: Barcelona (Spain) trial ClinicalTrials.gov, ID NCT05488496. Registered 29 July 2022 Prague (Czech Republic) trial ClinicalTrials.gov, ID NCT05522140. Registered August 25, 2022 Helsinki (Finland) trial ClinicalTrials.gov, ID NCT05507684. Registered August 12, 2022.

8 October 2026 in Frontiers in Psychology
Verified
Journal Article
Open access
PDF file
VPVeronika Papon
Veronika Papon
BJBeate Jahn
Beate Jahn
GSGaby Sroczynski
Gaby Sroczynski
JLJill Litt
Jill Litt
LCLaura Coll-Planas
Laura Coll-Planas
URUrsula Rochau
Ursula Rochau
Background: Social prescribing appears to be an effective intervention to reduce loneliness. More evidence is needed on the long-term benefits of nature-based social prescribing (NBSP) to alleviate loneliness. Objective: We aimed to evaluate the long-term effectiveness, in terms of life expectancy (in life years: LY), quality-adjusted life expectancy (in quality-adjusted life years: QALYs), and loneliness-free years (LFYs), of a NBSP intervention compared to active control (AC) as loneliness-reduction strategy among adults in Spain. Methods: We developed a Markov state-transition model where participants moved between different health states to estimate LYs, QALYs, and LFYs. Loneliness, reduced loneliness, or relapsed loneliness, was combined with either being in good health or one of the following loneliness-related diseases: cardiovascular diseases, diabetes mellitus type2, depression, anxiety, and dementia. Death from other causes, loneliness-disease-related death and suicide were considered. A lifelong time horizon was applied to evaluate long-term health outcomes of NBSP and AC. The model was populated with data from the “Friends in Nature” (FiN) pragmatic randomized controlled trial conducted in Barcelona (Spain) within the EU Horizon 2020 RECETAS project supplemented with Spanish data. FiN, a nature-based, facilitator-led group-based social prescribing model was compared to AC. We followed a Spanish cohort with a mean age of 61 years, comprising 80% women, experiencing loneliness. Several scenario and sensitivity analyses were performed. Results: NBSP resulted in 23.98 LYs, 15.15 QALYs, and 10.73 LFYs, versus 23.68 LYs, 14.76 QALYs, and 8.11 LFYs with AC. This corresponds to gains of 0.30 LYs, 0.39 QALYs and 2.62 LFYs for a Spanish cohort of lonely adults. Results remained robust in scenario analyses. Deterministic sensitivity analysis showed that all incremental outcomes were most sensitive to assumptions regarding the relative intervention effectiveness in reducing loneliness after six to twelve months, the relapse probability during this period, and the increased mortality risk associated with loneliness. Results of the PSA suggested NBSP as the optimal strategy under parameter uncertainty in terms of LYs, QALYs, and LFYs in 89% of all simulations. Conclusion: Our analyses suggest that NBSP is effective over the long-term in reducing loneliness and improving health outcomes in Spain. Further research, including a cost-effectiveness analysis, is needed to better inform decision-makers and support the implementation of NBSP within healthcare systems across different countries. Clinical trial registration: ClinicalTrials.gov , identifier NCT05488496.